Back to search

National and Kapodistrian University of Athens

Αξιολόγηση του άξονα CD40/CD40L ως βιοδείκτη πρόγνωσης και καρδιοτοξικότητας σε ασθενείς με καρκίνο του μαστού

Abstract

dc:description

Some breast cancer treatments can affect the heart, even when they are effective against cancer. Detecting early signs of heart injury during treatment is important so that doctors can monitor patients more closely and reduce the risk of long-term heart problems. This study examines whether changes in two blood markers linked to inflammation, CD40 and CD40 ligand, are associated with the development of reduced heart function in women receiving treatment for breast cancer. Wer aim to determine whether repeated measurement of these markers during therapy can help identify patients who may be at higher risk of treatment-related heart dysfunction. If confirmed in larger studies, these findings may support the development of better monitoring strategies in cardio-oncology and improve understanding of how inflammation contributes to heart injury during cancer treatment.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Efthymiou, Georgia
  • Ευθυμίου, Γεωργία

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62914

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Efthymiou, Georgia; Ευθυμίου, Γεωργία. Αξιολόγηση του άξονα CD40/CD40L ως βιοδείκτη πρόγνωσης και καρδιοτοξικότητας σε ασθενείς με καρκίνο του μαστού. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/62914